APA (7th ed.) Citation

Wang, H., Liu, Y., Yang, H., Wang, S., Cui, G., Ma, J., . . . Geng, C. (2022). Pyrotinib-based therapy for patients with HER2-positive breast cancer: A multicenter, real-world study. Journal of clinical oncology, 40(16_suppl), 1040. https://doi.org/10.1200/JCO.2022.40.16_suppl.1040

Chicago Style (17th ed.) Citation

Wang, Haoqi, et al. "Pyrotinib-based Therapy for Patients with HER2-positive Breast Cancer: A Multicenter, Real-world Study." Journal of Clinical Oncology 40, no. 16_suppl (2022): 1040. https://doi.org/10.1200/JCO.2022.40.16_suppl.1040.

MLA (9th ed.) Citation

Wang, Haoqi, et al. "Pyrotinib-based Therapy for Patients with HER2-positive Breast Cancer: A Multicenter, Real-world Study." Journal of Clinical Oncology, vol. 40, no. 16_suppl, 2022, p. 1040, https://doi.org/10.1200/JCO.2022.40.16_suppl.1040.